Litcius/Paper detail

Hyperferritinemia in critically ill COVID-19 patients – Is ferritin the product of inflammation or a pathogenic mediator?

Jenifer Gómez‐Pastora, Mitchell Weigand, James Kim, Xian Wu, Jacob Strayer, Andre F. Palmer, Maciej Zborowski, Mark H. Yazer, Jeffrey J. Chalmers

2020Clinica Chimica Acta245 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)MediatorCritically illFerritinInflammation2019-20 coronavirus outbreakMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Inflammatory mediatorImmunologyVirologyIntensive care medicineInternal medicineDiseaseOutbreakInfectious disease (medical specialty)COVID-19 Clinical Research StudiesIron Metabolism and DisordersHemoglobinopathies and Related Disorders
Hyperferritinemia in critically ill COVID-19 patients – Is ferritin the product of inflammation or a pathogenic mediator? | Litcius